pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Definium Therapeutics, Inc. ($DFTX) · catalysts · pharmadog
← back to Definium Therapeutics, Inc.
Catalysts for $DFTX
2
tracked
Aug 6, 2026
earnings
2mo ago
Definium Therapeutics, Inc. earnings
Definium Therapeutics, Inc.
→
ACTIVE_NOT_RECRUITING
phase readout
NCT06941844: A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
Definium Therapeutics, Inc.
→
$DFTX
37.40
-0.53%
$DFTX
37.40
-0.53%
